论文信息 - Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial - 字舞流文

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial

J. Rubio | S. Krudsood | A. Llanos-Cuentas | S. Duparc | C. Beaumont | Justin A. Green | Nick Carter | Ronnatrai Rueangweerayut | Zhengyu Xue | Maxine Taylor | P. S. St Jean | G. Koh | J. Green